Summit Therapeutics Inc. (SMMT) at a glance

Summit Therapeutics Inc. (SMMT) is a Healthcare company. It trades at $14.2. It does not pay a dividend. Vestovix scores it 47/100 overall. Its strongest dimension is Safety (60/100) and its weakest is Momentum (19/100).

Price
$14.20
Market cap
n/a
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$12.55 to $30.98
Vestovix Score47/ 100How this works
Value
50
Growth
50
Income
40
Safety
60
Momentum
19